CIK 0001531177
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800625749
- Phone
- +1 415-889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- 4 Grant or award Chief Financial Officer acquired 315,421 shares (grant or award)
- 4 Open-market sale President and CEO sold 15,917 shares at $5.16 ($82,195)
- 4 Open-market sale Chief Technology Officer sold 3,414 shares at $5.16 ($17,630)
- 4 Open-market sale Chief Legal Officer sold 4,538 shares at $5.16 ($23,434)
- 4 Open-market sale Chief Operating Officer sold 5,443 shares at $5.16 ($28,108)
- 4 Shares withheld for taxes Chief Technology Officer gave up 2,425 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 8,975 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,227 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,464 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 2,852,036 shares at $5.86 ($16,712,931)
- 4 Open-market buy Director bought 144,000 shares at an average $3.46 ($497,918)
- 4 Open-market buy Director bought 521,855 shares at an average $3.37 ($1,760,511)
- 4 Option exercise Chief Technology Officer acquired 150,000 shares (option exercise)
- 4 Open-market buy Director bought 188,796 shares at an average $2.39 ($450,433)
- 4 Open-market buy Director bought 127,003 shares at an average $2.19 ($277,971)
- 4 Grant or award Chief Commercial Officer acquired 747,572 shares (grant or award)
- 4 Open-market buy Director bought 3,462 shares at $2.00 ($6,914)
- 4/A Grant or award Director acquired 27,034 shares (grant or award)
- 4 Option exercise Chief Operating Officer acquired 37,668 shares (option exercise)
- 3 Insider Initial Statement of Ownership
Page 8 of 12 · 225 filings